Publisher
Springer Science and Business Media LLC
Subject
Physiology (medical),Cardiology and Cardiovascular Medicine
Reference6 articles.
1. Tardos JG, Ronk CJ, Patel MY, Koren A, Kim MH. US antiarrhythmic drug treatment for patients with atrial fibrillation: an insurance claims-based report. J Am Heart Assoc. 2021;10(6):e016792. https://doi.org/10.1161/JAHA.120.016792.
2. Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics – 2022 update: a report from the American Heart Association. Circulation. 2022;145:e153–639. https://doi.org/10.1161/CIR.0000000000001052.
3. LaMori JC, Mody SH, Gross HJ, DiBonaventura MD, Patel AA, Schein JR, Nelson WW. Burden of comorbidities among patients with atrial fibrillation. Ther Adv Cardiovasc Dis. 2013;7(2):53–62.
4. January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland Jr JC, Ellinor PT, Ezekowitz MD, Field MD, Furie KL, Heidenreich PA, Murray KT, Shea JB, Tracy CM, Yancy CW, 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation. Heart Rhythm. 2019;16:e66–93. https://doi.org/10.1016/j.hrthm.2019.01.024.
5. National Center for Health Statistics. Health, United States, 2019: Figure 39. Hyattsville, MD. 2019. Available from: https://www.cdc.gov/nchs/hus/data-finder.htm. Accessed 12 Aug 2022.